Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Annika Andersson-Sjöland"'
Autor:
Janelle Drouin‐Ouellet, Shong Lau, Per Ludvik Brattås, Daniella Rylander Ottosson, Karolina Pircs, Daniela A Grassi, Lucy M Collins, Romina Vuono, Annika Andersson Sjöland, Gunilla Westergren‐Thorsson, Caroline Graff, Lennart Minthon, Håkan Toresson, Roger A Barker, Johan Jakobsson, Malin Parmar
Publikováno v:
EMBO Molecular Medicine, Vol 9, Iss 8, Pp 1117-1131 (2017)
Abstract Direct conversion of human fibroblasts into mature and functional neurons, termed induced neurons (iNs), was achieved for the first time 6 years ago. This technology offers a promising shortcut for obtaining patient‐ and disease‐specific
Externí odkaz:
https://doaj.org/article/e73f830423c14f13b05bd7371e571788
Autor:
Lena Thiman, Hillevi Larsson, Gunilla Westergren-Thorsson, Leif Bjermer, Anna-Karin Larsson-Callerfelt, Oskar Hallgren, Catharina Müller, Leif Eriksson, Annika Andersson-Sjöland
Publikováno v:
Respiratory medicine. 166
Chronic lung allograft dysfunction including Bronchiolitis obliterans syndrome (BOS) is common after lung transplantation. Histologically, BOS is recognized as fibrotic lesions with accumulated extracellular matrix (ECM) in small airways. Lung fibrob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1b4ee471d32bde1cf1d03e0f6aa436
https://pubmed.ncbi.nlm.nih.gov/32250877
https://pubmed.ncbi.nlm.nih.gov/32250877
Autor:
Mariam Bagher, Leif Bjermer, Gunilla Westergren-Thorsson, Claes-Göran Löfdahl, Lena Thiman, Anna-Karin Larsson-Callerfelt, Annika Andersson-Sjöland, Oskar Hallgren
Publikováno v:
Respirology. 23:68-75
Background and objective Involvement of pulmonary vascular remodelling is a characteristic sign in COPD. Vascular mediators such as vascular endothelial growth factor (VEGF) and prostacyclin may regulate fibroblast activity. The objective was to stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1c257fa9140f7993452d38d6c90dcf6
https://doi.org/10.1111/resp.13142
https://doi.org/10.1111/resp.13142
Autor:
Thomas N. Wight, Ya-Ting Chang, Christian Norvik, Inger Eriksson, Pamela Y. Johnson, Annika Andersson-Sjöland, Ulf Hedin, Xiaofang Cao, Lena Kjellén, Christina K. Chan, Gunilla Westergren-Thorsson, Christian Westöö, Staffan Johansson, Karin Tran-Lundmark
Publikováno v:
Pulmonary Circulation. 6:347-359
Pulmonary arterial hypertension (PAH) is a lethal condition for which there is no effective curative pharmacotherapy. PAH is characterized by vasoconstriction, wall thickening of pulmonary arteries, and increased vascular resistance. Versican is a ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d8831539ffa5ee9a42d0de83b7edc57
https://doi.org/10.1086/686994
https://doi.org/10.1086/686994
Autor:
Annika Andersson Sjöland, Gunilla Westergren-Thorsson, Ulrika Blank Savukinas, Sara Rolandsson Enes
Publikováno v:
Stem Cells. 34:1437-1444
Mesenchymal stem or stromal cells (MSCs), a heterogeneous subset of adult stem/progenitor cells, have surfaced as potential therapeutic units with significant clinical benefit for a wide spectrum of disease conditions, including those affecting the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60981cf2847b926be1f1bfaac8da6fbe
https://doi.org/10.1002/stem.2357
https://doi.org/10.1002/stem.2357
ROS-induced endothelial stress contributes to pulmonary fibrosis through pericytes and Wnt signaling
Publikováno v:
Laboratory Investigation. 96:206-217
Pulmonary fibrosis is a grave diagnosis with insidious progression, generally considered as a consequence of aberrant epithelial wound healing and excessive scarring. This process is commonly modeled in animals by local bleomycin administration, resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278da31aabd294ce381159994807572b
https://doi.org/10.1038/labinvest.2015.100
https://doi.org/10.1038/labinvest.2015.100
Autor:
Mariam Bagher, Claes-Göran Löfdahl, Anna-Karin Larsson-Callerfelt, Gunilla Westergren-Thorsson, Oskar Hallgren, Lena Thiman, Leif Bjermer, Annika Andersson Sjöland
Publikováno v:
Airway Pharmacology and Treatment.
Pulmonary vascular remodelling is a characteristic sign in different lung disorders. Vascular endothelial growth factor (VEGF) is a key mediator in vascular remodelling. The objective was to study the role of VEGF on fibroblast activity, such as extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::546933efb693a541bdc00a7a19a0185f
https://doi.org/10.1183/1393003.congress-2017.pa1045
https://doi.org/10.1183/1393003.congress-2017.pa1045
Autor:
Per Ludvik Brattås, Daniella Rylander Ottosson, Romina Vuono, Lucy M Collins, Lennart Minthon, Janelle Drouin-Ouellet, Johan Jakobsson, Annika Andersson Sjöland, Daniela A. Grassi, Caroline Graff, Shong Lau, Malin Parmar, Håkan Toresson, Roger A. Barker, Karolina Pircs, Gunilla Westergren-Thorsson
Publikováno v:
BASE-Bielefeld Academic Search Engine
EMBO Molecular Medicine
EMBO Molecular Medicine
Direct conversion of human fibroblasts into mature and functional neurons, termed induced neurons (iNs), was achieved for the first time 6 years ago. This technology offers a promising shortcut for obtaining patient‐ and disease‐specific neurons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c821b0e0bcf5dd008b2082f6af5029
https://kar.kent.ac.uk/78971/1/Drouin-Ouellet_et_al-2017-EMBO_Molecular_Medicine.pdf
https://kar.kent.ac.uk/78971/1/Drouin-Ouellet_et_al-2017-EMBO_Molecular_Medicine.pdf
Autor:
Gunilla, Westergren-Thorsson, Mariam, Bagher, Annika, Andersson-Sjöland, Lena, Thiman, Claes-Göran, Löfdahl, Oskar, Hallgren, Leif, Bjermer, Anna-Karin, Larsson-Callerfelt
Publikováno v:
Respirology (Carlton, Vic.). 23(1)
Involvement of pulmonary vascular remodelling is a characteristic sign in COPD. Vascular mediators such as vascular endothelial growth factor (VEGF) and prostacyclin may regulate fibroblast activity. The objective was to study the synthesis of VEGF a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8672bfa6b2bba6e0e49565c09a6de005
https://pubmed.ncbi.nlm.nih.gov/28834088
https://pubmed.ncbi.nlm.nih.gov/28834088
Autor:
Annika Andersson-Sjöland, Leif Eriksson, Claus B. Andersen, Catharina Müller, Hans Henrik Schultz, Martin Iversen, Gunilla Westergren-Thorsson
Publikováno v:
BMJ Open Respiratory Research
Müller, C, Andersson-Sjöland, A, Schultz, H H, Eriksson, L T, Andersen, C B, Iversen, M & Westergren-Thorsson, G 2017, ' Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation ', BMJ Open Respiratory Research, vol. 4, no. 1, e000177 . https://doi.org/10.1136/bmjresp-2016-000177
Müller, C, Andersson-Sjöland, A, Schultz, H H, Eriksson, L T, Andersen, C B, Iversen, M & Westergren-Thorsson, G 2017, ' Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation ', BMJ Open Respiratory Research, vol. 4, no. 1, e000177 . https://doi.org/10.1136/bmjresp-2016-000177
Background: Chronic lung allograft dysfunction in the form of bronchiolitis obliterans syndrome (BOS) is the main cause of death beyond 1-year post-lung transplantation. The disease-initiating triggers as well as the molecular changes leading to fibr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b536e20e21776eb93e1bced0caa5c38b
https://pubmed.ncbi.nlm.nih.gov/28469930
https://pubmed.ncbi.nlm.nih.gov/28469930